hydroxyl radical has been researched along with lysophosphatidylcholines in 3 studies
Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
---|---|---|---|---|---|
10,147 | 26 | 3,657 | 5,058 | 39 | 976 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaudeux, JL; Bonnefont-Rousselot, D; Delattre, J; Gardes-Albert, M; Legrand, A; Peynet, J; Therond, P | 1 |
Bibak, N; DeOcampo, R; Gabrielian, A; Hajdu, J; Rosseto, R; Shah, T | 1 |
Miyashita, M; Obata, T | 1 |
3 other study(ies) available for hydroxyl radical and lysophosphatidylcholines
Article | Year |
---|---|
Comparison of the effects of O2*-/HO* free radical- and copper ions-oxidized LDL or lipoprotein(a) on the endothelial cell releases of tissue plasminogen activator and plasminogen activator inhibitor-1.
Topics: Copper; Dose-Response Relationship, Radiation; Endothelium, Vascular; Humans; Hydroxyl Radical; Ions; Ketocholesterols; Lipoprotein(a); Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phosphatidylcholines; Plasminogen Activator Inhibitor 1; Superoxides; Tissue Plasminogen Activator; Umbilical Veins | 2001 |
A new synthesis of lysophosphatidylcholines and related derivatives. Use of p-toluenesulfonate for hydroxyl group protection.
Topics: Benzenesulfonates; Fatty Acids; Fluorescence Resonance Energy Transfer; Hydroxyl Radical; Indicators and Reagents; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Molecular Conformation; Phospholipids; Phosphorylation; Stereoisomerism | 2007 |
Protective effect of diltiazem, a L-type calcium channel antagonist, on lysophosphatidylcholine-enhanced hydroxyl radical generation by MPP(+) in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Corpus Striatum; Diltiazem; Dose-Response Relationship, Drug; Hydroxyl Radical; Lysophosphatidylcholines; Male; Protective Agents; Protein Kinase C; Rats; Rats, Wistar | 2013 |